Sched.com Conference Mobile Apps
DIA 2025 Global Annual Meeting
DIA 2025 Global Annual Meeting
Sign up
or
log in
to add sessions to your schedule and sync them to your phone or calendar.
Schedule
Speakers
Search
Menu
Schedule
Speakers
Search
HS
Hamada Sherief
EDA, Egypt
Director of the General Administration of Registration of...
Molly Shields
Duke-Margolis Institute For Health Policy, United States
Policy Research Assistant
Allison Cuff Shimooka
TransCelerate Biopharma Inc, United States
Chief Operating Officer
Judy Shin
School of Pharmacy, Sungkyunkwan University, Korea, Republic of
Professor
Sooyoon Shin
Verily, United States
Senior Manager, Digital Biomarkers
Carolyn Shore
National Academies, United States
Director
AS
Anand Shroff
Verantos, United States
President
RS
Ria Siagian
Indonesia Food and Drug Authority, Indonesia
Director, Drug Registration Directorate
Steve Sibley
Certara, United States
Vice President, Global Submissions and Submissions Leadership
Hiiti Sillo
World Health Organization (WHO), Switzerland
Unit Head, Regulation and Safety, Department of Regulation and...
Cristiano Silva
Albert Einstein Israelite Hospital, Brazil
Data Manager
Dyke Simpson
Syneos Health, United States
Sr Account Development Mgr
Sandeep Singh
Genmab, United States
Associate Director, Global Medical Information
AS
Arup Sinha
FDA, United States
Statistician, OTS, CDER
Louise Lind Skov
Novo Nordisk A/S, Denmark
Head of Content Digitalisation
Aaron Smith
Unlearn.AI, United States
Founder, Machine Learning Scientist
Del Smith
Acclinate Inc., United States
Co-Founder and Chief Executive Officer
Cary Smithson
LeapAhead Solutions, Inc., United States
Managing Partner
Rachel Sobel
Regeneron Pharmaceuticals Inc., United States
Vice President, Head of Pharmacoepidemiology & Risk Management...
Mariana Socal
Johns Hopkins Bloomberg School of Public Health, United States
Associate Professor
Cecilia Speck
Novartis, United States
Post-Doctoral Fellow
Dianne Spillman
FDA, United States
Associate Director, Global and Regulatory Outreach, OCE
Alicia Staley
Medidata, a Dassault Systèmes Company, United States
Chief Patient Officer
Louis Stancato
Indiana Biosciences Research Institute, United States
VP Enabling Technologies
Nicole Stansbury
Premier Research, United States
Senior Vice President Global Clinical Operations
ES
Eddie Stern
The Breathing App, Inc, United States
CEO
AS
Alan Stevens
Abbvie, United States
Global Head, Complex Devices and Drug Delivery Systems
Benjamin Stevens
GlaxoSmithKline, United States
Director CMC Policy and Advocacy
Mark Stewart
Friends of Cancer Research, United States
Vice President, Science Policy
Yoshiko Stowell
Kenai Therapeutics, United States
Vice President Regulatory Affairs
Carmit Strauss
Takeda, United States
Executive Director, Head of Risk Management and Organ Toxicity
Mariette Boerstoel Streefland
Bristol-Myers Squibb Company, United States
Senior Vice President, Patient Safety Officer
Margaret Studzinska
MMS Holdings, United States
Senior Director, Regulatory and Medical Writing
Nancy Styple
Bayer AG, United States
Project Management Leader
CS
Cheng Su
Biomarin Pharmaceutical, United States
Executive Director, Data Sciences and Analytics
Ling Su
Shenyang Pharmaceutical University, Yeehong Business School, China
Research Fellow
Yu Fa Su
Taiwan Center For Drug Evaluation, Taiwan
Project Manager
Indri Supriadi
Indonesia Ministry of Health, Indonesia
Director, Center for Biomedical and Health Genomics and INA-CRC
Andreas Sutter
Bayer AG, Germany
Senior Program Management Leader
Toru Suzuki
Novartis Pharma, Japan
Head, Regulatory and Development policy
Kimberly Tableman
Espero, United States
Founder & CEO
Lawrence Tallon
Medicines and Healthcare products Regulatory Agency, United Kingdom
Chief Executive Officer
Nancy Tam
Pfizer Inc, United States
Head of Medical Writing
MT
Mihail Tanev
FindMeCure Ltd, Bulgaria
Medical Advisor
QT
Qian Tang
University of Iowa, United States
ST
Sarah Tanios
Purdue University, United States
Pharmacovigilance and Medication Safety Fellow
UT
Umit Tapan
Boston University, United States
Assitant Professor of Medicine
Rosa Tarng
Takeda, United States
Translational Program Management
BT
Barrett Tenbarge
U.S. Senate HELP Committee, United States
General Counsel
Parth Thesia
Whatfix , United States
Solutions Consulting - LifeSciences NA
Jess Thompson
Clinical Research Pro, United States
Founder, CEO
Andrew Thomson
European Medicines Agency, Netherlands
Statistician, Methodology Taskforce
Gert Thurau
F. Hoffmann-La Roche Ltd, Switzerland
Head of CMC Regulatory Policy for Manufacturing Technology Innovation...
Jayashree Tikhe
Dassault Systemes, United States
Senior Product Marketing Manager
Lauren Tobe
Eli Lilly and Company, United States
Director, Regulatory Policy and Strategy
Darren Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute, United States
Professor
Natalie Tolli
AbbVie, Inc., United States
Vice President, Regulatory Intercontinental/RPI
Sara Torgal
DIA, Switzerland
Global Regulatory Policy Lead
Michael Torok
Genentech, A Member of the Roche Group, United States
Vice President, Global Head of Quality Assurance Programs
QT
Quyen Tran
FDA, United States
Science Policy Analyst, OND, CDER
Sharleen Traynor
Durham Tech, United States
Instructor
Phil Tregunno
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Deputy Director - Patient Safety Monitoring
Sarah Tremethick
Roche Products Limited, United Kingdom
Global Consortia Program Lead and Global Member Network Executive...
Kiernan Trevett
Genentech, A Member of the Roche Group, United States
Quality Policy Lead
Jennifer Trevor
Astellas, United States
Director-Global Category Lead- Development
JT
Julie Tripp
Mind Medicine Inc., United States
Senior Director of Toxicology
Darshini Trivedi
Amgen, Inc, United States
Global Regulatory Affairs and Product Strategy
MT
Michael Trulli
Evinova, United States
Associate Director, Science Capability and Delivery
Ran Tu
Georgetown University, United States
Phd Student
Jennifer Tucker
Roche Diagnostics, United States
Global Head of Regulatory Affairs, Pathology Lab
Rachel Turow
Skadden, United States
Of Counsel, FDA Regulatory Law
Peter Twomey
European Medicines Agency, Netherlands
Head of Inspections
Cathy Tyrrell
CSL Seqirus, United States
Head of Medical Writing and Disclosure
Yoshiaki Uyama
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Pujita Vaidya
Sanofi, United States
Director, Regulatory Science and Policy
James Valentine
Hyman, Phelps & McNamara, PC, United States
Director
JV
Jacqueline Vanderpuye-Orgle
Parexel, United States
Vice President
Alice Vanneste
KU Leuven, Belgium
PhD Student
Maria Vassileva
DIA, United States
Chief Science and Regulatory Officer
Sarah Vaughan
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Head of Vigilance Operations
CV
Chris Venezia
ProofPilot, United States
Chief Executive Officer
RV
Rishi Verma
Roche & Stethy, Australia
Medical Director
Rebecca Vermeulen
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
PV
Patrice Verpillat
European Medicines Agency
Head of Real World Evidence
Alyssa Vincze
Milliman IntelliScript , United States
Principal and Director, R&D
Mukul Virmani
Gilead, United States
Director, Clinical Data Science, AI Research Center
Corinne de Vries
European Medicines Agency, Netherlands
Head of Translational Sciences Office
James Wabby
AbbVie, United States
Global Head, Regulatory Affairs, Emerging Technologies and...
Jason Wakelin-Smith
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Expert GCP Inspector and Head of Compliance Expert Circle
Paula Walker
Roche Products Ltd., United Kingdom
Global Head of Risk Based Quality Management
Stuart Walker
Centre for Innovation In Regulatory Science (CIRS), United Kingdom
Professor and Consultant
AW
Adrienne Walstrum
Merck, United States
Senior Director, Global Trial Optimization
EW
Echo Wang
Merck & Co., Inc, United States
Director, Outcome Research
Jialu Wang
Vertex Pharmaceuticals, United States
Statistician
Shirley Wang
Harvard Medical School, United States
Associate Professor of Medicine
Wenquan Wang
Pfizer, United States
Senior Director
William Wang
Merck & Co, Inc, United States
President
Yun Wang
FDA, United States
Deputy Division Director, CDER/OTS/OB
Nicole Ward
Bristol Myers Squibb, United States
Senior Product Manager, Business Insights & Technology
SW
Shinya Watanabe
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer (Epidemiology)
Eli Weinberg
Bain & Co., United States
Partner
Helen West
Evinova, United States
Senior Director, Innovative Patient Recruitment
Ria Westergaard
Evernorth Clinical Trial and RWE Solutions, United States
Head of Product Strategy and Innovation
BW
Bryce Whited
WCI Medtech, United States
Founder and Principal Consultant
MW
Madeleine Whitehead
Roche, United Kingdom
RBQM CoE - Head
Robin Whitsell
Whitsell Innovations, Inc., United States
President
Jenna Wildeman
University of Washington, United States
PharmD Candidate
Jamie Wilkins
Pfizer Inc, United States
Head, Risk Management Center of Excellence
Kim Wilkinson
Alexion RDU, Astrazeneca, United States
Associate Director, Medical Writing
Donald Williams
Boehringer Ingelheim Pharmaceuticals, Inc., United States
Global Patient Safety and Pharmacovigilance, Regulatory Reporting
Gina Williamson
Illingworth, A Syneos Health Company, Spain
Associate Director Site solutions
Luman Wing
Management Consultants, United States
Consultant, Nonclinical
Steve Winitsky
Parexel International, United States
Senior Vice President, Technical
Leanne Woehlke
SOGLIA - Entrada Ventures Group, United States
Executive Vice President, SOGLIA
Jerzy Wojcik
EdgeOne Medical, United States
VP, Regulatory & Quality Services
Lisa Wolf
FDA, United States
Deputy Director, Division of Pharmacovigilance I, CDER
Thad Wolfram
EmVenio Research, United States
Chief Strategy Officer
MW
Marion Wolfs
Johnson & Johnson, Netherlands
Associate Director Risk Management & Central Monitoring
Shyard Wong
Sanofi, France
Global Head, Clinical Quality and Continuous Improvement
MW
Mathew Woodwark
AstraZeneca, United Kingdom
Head of Data Standards, Interoperability and Governance
Gillian Woollett
Samsung Bioepis, United States
Vice President, Head Regulatory Strategy and Policy
Benjamin Worley
LabConnect, United States
Senior Director, Sustainability & ESG
Amy Xia
Amgen Inc., United States
Vice President, Center for Design and Analysis
Richard Xie
RA Capital Management, United States
Senior Health Economist
BY
Beno Yakubu
National Agency for Food and Drug Administration, Nigeria
Head of Clinical Trial Department
Baiyu Yang
Roche Molecular Systems, United States
Principal Quantitative Scientist
DY
David Yao
Novartis, United States
Associate Director, Regulatory Affairs CMC
Tarik Yardibi
Takeda Pharmaceuticals, United States
Director, Sensing and Measurement
Naoyuki Yasuda
Pharmaceuticals and Medical Devices Agency, Japan
Takayuki Yasuda
Chugai Pharmaceutical Co., Ltd., Japan
Statistical Programmer
Debra Yeskey
CEPI, United States
Head of Regulatory Policy and Intelligence
Eunice Lin Youhanna
Microsoft, Canada
Industry Advisor
Amira Younes
MSD, United Arab Emirates
Director, Europe, Middle East & Africa (EMEA) Global Regulatory...
Rumi Young
Novo Nordisk, United States
Director, Regulatory Policy
Shou Yuan
Taimei Technology Inc., United States
Director, Global Solutions
Di Zhang
Teva, United States
Associate Director of RWE Statistics
JZ
Jianwu Zhang
National Medical Products Administration, China
Division Director, Drug Registration Department
Teresa Zhang
Beone Medicines, United States
Safety Scientist
Wei Zhang
Boehringer Ingelheim, China
SVP, Head of Medicine, Greater China
XZ
Xiang Zhang
CSL Behring, United States
Head of Medical Affairs and HTA Statistics/Co-lead FORExcellence
LZ
Liang Zhao
University of California San Francisco, United States
Professor and Director for Center of Global Regulatory Science and...
Siqian Zheng
University of Macau, China
Doctor of Biomedical sciences
John Zhong
REGENXBIO, Inc., United States
Vice President, Head of Biometrics
FZ
Feng Zhu
China Center for Food and Drug International Exchange (CCFDIE), China
Director, Cooperation Department
Martine Zimmermann
Ipsen , France
Senior Vice President, Head of Global Regulatory Affairs
Bianca Zimon
ANVISA, Brazil
Health Regulation Specialist
Vadim Zipunnikov
Johns Hopkins Bloomberg School of Public Health, United States
Associate Professor
RZ
Regina Zopf
FDA, United States
Senior Medical Officer, CDER
Andrea Zuleta
Abbvie, United States
Manager, Office of Health Literacy
CZ
Cecilia Zvosec
ZS, United States
Strategy & Insights
1
2
3
4
Share Modal
Share this link via
Or copy link
Copy